Thermo Fisher Scientific Inc. Stock Deutsche Boerse AG
Equities
TN80
CA88355G1000
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 EUR | -0.71% | -2.11% | 0.00% |
Sales 2024 * | 43.02B 39.63B | Sales 2025 * | 46.1B 42.46B | Capitalization | 223B 205B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B 5.66B | Net income 2025 * | 6.97B 6.42B | EV / Sales 2024 * | 5.73 x |
Net Debt 2024 * | 23.49B 21.64B | Net Debt 2025 * | 19.14B 17.63B | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
36.7
x | P/E ratio 2025 * |
31.5
x | Employees | 122,000 |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | -0.71% | ||
1 week | -2.11% | ||
Current month | -0.71% | ||
3 months | -2.11% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-28 | 13.9 | -0.71% |
24-05-27 | 14 | 0.00% |
24-05-24 | 14 | -1.41% |
24-05-23 | 14.2 | +0.71% |
24-05-22 | 14.1 | -0.70% |
Delayed Quote Deutsche Boerse AG, May 28, 2024 at 09:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.37% | 195B | |
+18.54% | 144B | |
+29.76% | 111B | |
+2.32% | 65.19B | |
+13.76% | 53.02B | |
+2.68% | 50.28B | |
+6.50% | 44.15B | |
+1.67% | 36.45B | |
+20.28% | 31.33B |
- Stock Market
- Equities
- TMO Stock
- TN80 Stock